Zhao, Sizheng StevenJones, Gareth TMacfarlane, Gary JHughes, David MMoots, Robert JGoodson, Nicola J2021-01-142021-01-142021-07Zhao, S S, Jones, G T, Macfarlane, G J, Hughes, D M, Moots, R J & Goodson, N J 2021, 'Association between comorbidities and disease activity in axial spondyloarthritis : results from the BSRBR-AS', Rheumatology, vol. 60, no. 7, pp. 3189–3198. https://doi.org/10.1093/rheumatology/keaa7681462-0324ORCID: /0000-0003-2322-3314/work/88320307ORCID: /0000-0003-0016-7591/work/88320709https://hdl.handle.net/2164/15652Funding: The BSRBR-AS is funded by the British Society for Rheumatology (BSR) who have received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments. They have no input in determining the topics for analysis or work involved in undertaking it. We are grateful to the staff of the BSRBR-AS register and to the recruiting staff at the clinical centres, details of which are available at: http://www.abdn.ac.uk/bsrbr-as S.S.Z. analysed the data and wrote the manuscript, with significant input from all co-authors. G.J.M. and G.T.J. are Chief Investigator and Deputy Chief Investigator, respectively, on BSRBR-AS and designed the study and oversaw its conduct. In the current project they discussed results and provided input into drafts of the manuscript. Disclosure statement: The authors have declared no conflicts of interest.10802390engaxial spondylarthritisAScomorbiditydisease activitypatient globalspondylarthritisR MedicineSupplementary DataRJournal article10.1093/rheumatology/keaa768607